48.12 USD
+0.1 (+0.21%)
48.12 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
BRKR had a positive operating cash flow in the past year.
BRKR had positive earnings in each of the past 5 years.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
BRKR has a Return On Assets of -0.37%. This is in the better half of the industry: BRKR outperforms 64.91% of its industry peers.
BRKR's Return On Equity of -0.97% is fine compared to the rest of the industry. BRKR outperforms 64.91% of its industry peers.
BRKR has a Return On Invested Capital of 4.01%. This is in the better half of the industry: BRKR outperforms 68.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 13.99%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
In the last couple of years the Profit Margin of BRKR has declined.
BRKR has a Operating Margin of 8.99%. This is in the better half of the industry: BRKR outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR has a Gross Margin of 48.00%. This is comparable to the rest of the industry: BRKR outperforms 52.63% of its industry peers.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BRKR has more shares outstanding
BRKR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
BRKR has an Altman-Z score of 2.50. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.50, BRKR perfoms like the industry average, outperforming 59.65% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that BRKR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, BRKR is not doing good in the industry: 75.44% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.5 |
ROIC/WACC0.4
WACC10.08%
2.3 Liquidity
BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.85, BRKR is doing worse than 61.40% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, BRKR is doing worse than 85.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.10% in the past year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
BRKR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.96% yearly.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.14% yearly.
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.06, which indicates a rather expensive current valuation of BRKR.
82.46% of the companies in the same industry are more expensive than BRKR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.50, BRKR is valued at the same level.
With a Price/Forward Earnings ratio of 22.37, BRKR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 82.46% of the companies in the same industry.
BRKR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.93, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.06 | ||
| Fwd PE | 22.37 |
4.2 Price Multiples
84.21% of the companies in the same industry are more expensive than BRKR, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.19 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.69
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
5. Dividend
5.1 Amount
With a yearly dividend of 0.45%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.09, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
With a Dividend Yield of 0.45, BRKR pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.45% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
BRKR's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
48.12
+0.1 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners90.24%
Inst Owner Change6.35%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.31B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts78
Price TargetN/A
Short Float %13.26%
Short Ratio4.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.45% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)4.3%
PT rev (3m)3.71%
EPS NQ rev (1m)-0.21%
EPS NQ rev (3m)-24.7%
EPS NY rev (1m)-4.23%
EPS NY rev (3m)-6.92%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.06 | ||
| Fwd PE | 22.37 | ||
| P/S | 2.13 | ||
| P/FCF | N/A | ||
| P/OCF | 77.53 | ||
| P/B | 3.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.19 |
EPS(TTM)2
EY4.16%
EPS(NY)2.15
Fwd EY4.47%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.29%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.69
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.5 |
F-Score5
WACC10.08%
ROIC/WACC0.4
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year14.16%
EBIT Next 3Y13.08%
EBIT Next 5Y8.97%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status of BRUKER CORP (BRKR) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP (BRKR) stock?
The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -20.74% in the next year.
Is the dividend of BRUKER CORP sustainable?
The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.